Raymond James analyst Dane Leone maintains Simulations Plus (NASDAQ:SLP) with a Outperform and raises the price target from $54 to $70.
PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing
PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q2 2022 revenue was CA$2.1 million, a 375% increase compared to CA$446,000 in Q2 2021.